DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Cortrosyn is a drug marketed by Amphastar Pharms Inc and is included in one NDA.
The generic ingredient in CORTROSYN is cosyntropin. There are two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the cosyntropin profile page.
A generic version of CORTROSYN was approved as cosyntropin by MYLAN INSTITUTIONAL on December 17th, 2009.
Summary for CORTROSYN
Recent Clinical Trials for CORTROSYN
Identify potential brand extensions & 505(b)(2) entrants
|National Heart, Lung, and Blood Institute (NHLBI)||N/A|
|National Institutes of Health (NIH)||N/A|
Pharmacology for CORTROSYN
|Drug Class||Adrenocorticotropic Hormone |
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Amphastar Pharms Inc||CORTROSYN||cosyntropin||INJECTABLE;INJECTION||016750-001||Approved Prior to Jan 1, 1982||AP||RX||Yes||Yes||Get Started Free||Get Started Free||Get Started Free|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|